Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Benlysta Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering. The report offers insights into Benlysta's ...
Benlysta (belimumab) is a brand-name drug prescribed for lupus in adults and some children. It comes as an intravenous (IV) infusion and subcutaneous injection. Benlysta’s cost with and without ...
Replacing a fuel injector typically costs between $300 and $4,000, depending on your vehicle's make, engine size and fuel system complexity. This out-of-pocket estimate includes both parts and labor, ...
Embecta aims to use Owen Mumford's Aidaptus auto-injector to help it transform into a broad-based medical supplies company. (iStock/Getty Images Plus) Diabetes hardware company embecta aims to look ...
Embecta, a company that develops diabetes management solutions, is moving into the auto-injection market with its latest planned acquisition. The Becton Dickinson & CO spinoff reported it would ...
If you or someone you love has an allergy that results in anaphylaxis, you know how important it is to administer epinephrine at the first sign of a reaction. Epinephrine is the frontline treatment ...
Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google The U.S. Food and Drug Administration (FDA) has approved Benlysta ...
The 200mg single-dose prefilled autoinjector allows pediatric patients to receive LN treatment at home via SC administration. The Food and Drug Administration (FDA) has approved Benlysta (belimumab), ...
The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with active lupus nephritis who are receiving ...
MONDAY, June 30, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved an autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results